American Oncology Network (AONC) Stock Statistics & Valuation Metrics

American Oncology Network has a market cap or net worth of $594.89M. The enterprise value is $377.00M.

American Oncology Network has 33,732,370 shares outstanding. The number of shares has decreased by -2.65% in one year.

American Oncology Network’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -6.56%.

The current PE Ratio of American Oncology Network is ―. American Oncology Network’s PEG ratio is 0.35.

In the last 12 months, American Oncology Network had revenue of 1.76B and earned -3.97M in profits. Earnings per share was -0.69.

In the last 12 months, operating cash flow was 74.12M and capital expenditures -21.04M, giving a free cash flow of 53.08M billion.

American Oncology Network pays an annual dividend of ―, resulting in a dividend yield of ―

American Oncology Network upcoming earnings date is Mar 26, 2026, Before Open (Confirmed).

American Oncology Network as a current ratio of 1.53, with Debt / Equity ratio of 785.08%

In the past 12 months, American Oncology Network has paid 2.50M in taxes.

American Oncology Network EV to EBITDA ratio is 84.81, with an EV/FCF ratio of -5.94.

American Oncology Network has $72.64M in cash and marketable securities with $147.37M in debt, giving a net cash position of -$74.73M billion.

Gross margin is 6.70%, with operating margin of -0.99%, and net profit margin of -0.23%.

The average price target for American Oncology Network is ―, which is 11.43% higher than the current price. The consensus rating is ―